The COVID-19 Pandemic: Data Analysis, Impacts and Future Considerations

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 364

فایل این مقاله در 17 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJMM-15-1_001

تاریخ نمایه سازی: 10 اسفند 1399

چکیده مقاله:

The 2019 novel coronavirus is another type of known coronaviruses; SARS-CoV-1 and MERS-CoV. The World Health Organization (WHO) has named the virus SARS-CoV-2 and its disease as coronavirus disease 2019 (abbreviated COVID-19). The first case of COVID-19 was reported in December 2019 in Wuhan, China. The epidemiological studies have shown that the disease is transmitted from animal to human, and the spread of the disease from person to person is rapidly expanding. Currently, the most important factor in preventing and controlling the spread of the disease is proper recognition, health care, and control measures. Given the importance of early detection and timely treatment of the disease, the use of nanoscale materials for the production of sensors and drug delivery system can be of great assistance to the researchers. In this context, we aimed to explain the effects of the prevalence of the disease worldwide and consider the different aspects of SARS-CoV-2.

نویسندگان

Pooya Parvizi

School of Engineering, University of Birmingham, Birmingham, United Kingdom

Milad Jalilian

Department of Physics, Faculty of Science, Razi University, Kermanshah, Iran

Hana Parvizi

Science Department, The University of British Columbia, Vancouver, Canada

Sara Amiri

Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran

Hamidreza Mohammad Doust

Department of Physical Education, Tarbiat Modares University, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Woo P, Lau S, Lam C, Lau C, Tsang A, ...
  • Li G, Fan Y, Lai Y, Han T, Li Z, ...
  • Chen L, Liu W, Zhang Q, Xu K, Ye G, ...
  • World Health Organization. Summary of probable SARS cases with onset ...
  • World Health Organization. MERS situation update January 2020. http://wwwemrowhoint/health-topics/mers-cov/mers-outbreakshtml. 2020. ...
  • Zhu N, Zhang D, Wang W, Li X, Yang B, ...
  • Chan JF-W, Kok K-H, Zhu Z, Chu H, To KK-W, ...
  • Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, ...
  • Lam TT-Y, Shum MH-H, Zhu H-C, Tong Y-G, Ni X-B, ...
  • World Health Organization. Coronavirus disease (COVID-2019) situation reports https://wwwwhoint/emergencies/diseases/novel-coronavirus-2019/situation-reports/. 2020. ...
  • Wilder-Smith A, Chiew CJ, Lee VJ. Can we contain the ...
  • Wu JT, Leung K, Leung GM. Nowcasting and forecasting the ...
  • Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics ...
  • Stafford N. Covid-19: Why Germany's case fatality rate seems so ...
  • Roser M, Ritchie H, Ortiz-Ospina E. Coronavirus Disease (COVID-19)-Statistics and ...
  • Marston HD, Folkers GK, Morens DM, Fauci AS. Emerging viral ...
  • Gates B. The Next Epidemic - Lessons from Ebola. New ...
  • World Health Organization. Marburg virus disease (15 February 2018). https://wwwwhoint/news-room/fact-sheets/detail/marburg-virus-disease. ...
  • World Health Organization. Ebola virus disease (10 February 2020). https://wwwwhoint/news-room/fact-sheets/detail/ebola-virus-disease. ...
  • Centers for Disease Control and Prevention. Hendra Virus Disease (HeV) ...
  • Centers for Disease Control and Prevention. The burden of the ...
  • Novel CPERE. The epidemiological characteristics of an outbreak of 2019 ...
  • Heymann DL, Shindo N. COVID-19: what is next for public ...
  • World Health Organization. Update 49 - SARS case fatality ratio, ...
  • Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, ...
  • World Health Organization. Middle East respiratory syndrome coronaviurs (MERS-CoV) fact ...
  • Virlogeux V, Fang VJ, Park M, Wu JT, Cowling BJ. ...
  • Huang C, Wang Y, Li X, Ren L, Zhao J, ...
  • Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, ...
  • Jian-ya G. Clinical characteristics of 51 patients discharged from hospital ...
  • Chen N, Zhou M, Dong X, Qu J, Gong F, ...
  • Wang D, Hu B, Hu C, Zhu F, Liu X, ...
  • Zhang Jj, Dong X, Cao YY, Yuan Yd, Yang Yb, ...
  • Wang Z, Yang B, Li Q, Wen L, Zhang R. ...
  • van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble ...
  • World Health Organization. Updated WHO advice for international traffic in ...
  • Xiang Y-T, Yang Y, Li W, Zhang L, Zhang Q, ...
  • Gostin LO, Wiley LF. Governmental Public Health Powers During the ...
  • Marketon JIW, Glaser R. Stress hormones and immune function. Cellular ...
  • Godbout JP, Glaser R. Stress-induced immune dysregulation: implications for wound ...
  • Chandra RK. Nutrition and the immune system from birth to ...
  • Calder PC, Kew S. The immune system: a target for ...
  • Marcos A, Nova E, Montero A. Changes in the immune ...
  • De la Fuente M. Effects of antioxidants on immune system ...
  • De Flora S, Grassi C, Carati L. Attenuation of influenza-like ...
  • Mukhtar M, Arshad M, Ahmad M, Pomerantz RJ, Wigdahl B, ...
  • Lin C-W, Tsai F-J, Tsai C-H, Lai C-C, Wan L, ...
  • Ryu YB, Jeong HJ, Kim JH, Kim YM, Park J-Y, ...
  • Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). ...
  • Li G, De Clercq E. Therapeutic options for the 2019 ...
  • Touret F, de Lamballerie X. Of chloroquine and COVID-19. Antiviral ...
  • Colson P, Rolain J-M, Lagier J-C, Brouqui P, Raoult D. ...
  • Monteil V, Kwon H, Prado P, Hagelkrüys A, Wimmer RA, ...
  • Wang J, Tang K, Feng K, Lv W. High Temperature ...
  • Oliveiros B, Caramelo L, Ferreira NC, Caramelo F. Role of ...
  • Wang L, Crameri G. Emerging zoonotic viral diseases. Rev sci ...
  • World Health Organization. WHO Director-General's opening remarks at the media ...
  • Holloway R, Rasmussen SA, Zaza S, Cox NJ, Jernigan DB, ...
  • Centers for Disease Control and Prevention. Pandemic Preparedness Resources. https://wwwcdcgov/coronavirus/2019-ncov/php/pandemic-preparedness-resourceshtml. ...
  • Organization WH. Key planning recommendations for Mass Gatherings in the ...
  • Keogh-Brown MR, Smith RD. The economic impact of SARS: how ...
  • Smith RD, Keogh-Brown MR, Barnett T, Tait J. The economy-wide ...
  • Centers for Disease Control Prevention. Cost of the ebola epidemic. ...
  • McKibbin WJ, Fernando R. The global macroeconomic impacts of COVID-19: ...
  • Wang X, Liu L-H, Ramstroem O, Yan M. Engineering nanomaterial ...
  • Larguinho M, Baptista PV. Gold and silver nanoparticles for clinical ...
  • Mokhtarzadeh A, Eivazzadeh-Keihan R, Pashazadeh P, Hejazi M, Gharaatifar N, ...
  • Draz MS, Shafiee H. Applications of gold nanoparticles in virus ...
  • Huang X, Li M, Xu Y, Zhang J, Meng X, ...
  • Hu TY, Frieman M, Wolfram J. Insights from nanomedicine into ...
  • نمایش کامل مراجع